Valuation: Lead Data Inc.

Market Cap 539M 16.74M 14.68M 13.6M 12.51M 23.67M 1.6B 24.13M 162M 63.58M 787M 62.87M 61.5M 2.72B P/E 2024
-3.97x
P/E 2025 -12.2x
Enterprise Value 568M 17.65M 15.48M 14.34M 13.19M 24.95M 1.69B 25.44M 171M 67.01M 829M 66.27M 64.82M 2.86B EV / Sales 2024
33.7x
EV / Sales 2025 5.13x
Free-Float
64.34%
Yield 2024 *
-
Yield 2025 -
3 years 2.27
Extreme 2.27
6.48
5 years 2.27
Extreme 2.27
6.48
10 years 1.89
Extreme 1.89
8.54
Manager TitleAgeSince
Chief Executive Officer - 17/08/2022
Director of Finance/CFO - 10/06/2022
Corporate Officer/Principal - 10/06/2022
Director TitleAgeSince
Director/Board Member - 10/06/2019
Chairman - 17/08/2022
Director/Board Member - 10/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-9.85%-.--%-.--%-2.19% 16.79M
+1.65%-0.96%+21.38%+4.53% 9.61B
+0.93%+1.42%+12.38%+0.79% 1.29B
+4.87%+1.75% - - 1.28B
+0.89%+4.61%+2.48%-10.12% 1.07B
-1.96%-8.62%+49.43%+26.54% 628M
-1.18%-1.06%-23.64%-67.79% 585M
+0.46%-0.23%+106.86%+165.77% 416M
+1.29%+1.73%-11.62%-14.21% 410M
-1.46%-7.42%-57.72%-82.36% 262M
Average -0.44%-1.46%+11.06%+2.33% 1.56B
Weighted average by Cap. +1.44%-0.57%+18.61%+3.66%

Financials

2024 2025
Net sales 15.47M 481K 422K 390K 359K 680K 46M 693K 4.65M 1.83M 22.59M 1.8M 1.77M 78.02M 111M 3.44M 3.02M 2.79M 2.57M 4.86M 329M 4.96M 33.3M 13.06M 162M 12.92M 12.63M 558M
Net income -134M -4.16M -3.65M -3.38M -3.11M -5.88M -398M -5.99M -40.26M -15.79M -195M -15.61M -15.27M -675M -44.02M -1.37M -1.2M -1.11M -1.02M -1.93M -131M -1.97M -13.25M -5.19M -64.3M -5.14M -5.02M -222M
Net Debt -16.95M -527K -462K -428K -394K -745K -50.43M -759K -5.1M -2M -24.76M -1.98M -1.94M -85.52M 29.12M 905K 794K 735K 676K 1.28M 86.61M 1.3M 8.76M 3.44M 42.53M 3.4M 3.32M 147M
Logo Lead Data Inc.
Lead Data Inc is a Taiwan-based company principally engaged in the trading business of medical equipment. The Company’s main products include continuous positive airway pressures (CPAP), hearing aids, oxygen concentrators, oxygen concentrators and rapid screening reagents for novel coronavirus pneumonia (COVID-19). CPAP can treat obstructive sleep apnea. It also has great benefits in improving sleep quality and solving snoring problems. The Company mainly operates in Taiwan and mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2443 Stock